167 However, as for infliximab, a nonsignificant trend towards a higher rate of serious side effects was noted, including infections, hypersensitivity reactions, autoimmune disease, and neoplasia. 166 Also, patients need to be tested for tuberculosis exposure before starting infliximab therapy.
← all excerpts
Sympathetic Ophthalmia: Where Do We Currently Stand on Treatment Strategies?
1
—
—